Aclarion (ACONW) Competitors $0.02 +0.00 (+4.07%) As of 03:15 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care AG & Co. KGaA Hims & Hers Health American Oncology Network (NASDAQ:AONC) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Which has higher valuation & earnings, AONC or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Oncology Network$1.34BN/AN/AN/AN/AAclarion$54.60KN/AN/AN/AN/A Does the media prefer AONC or ACONW? In the previous week, American Oncology Network had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for American Oncology Network and 1 mentions for Aclarion. Aclarion's average media sentiment score of 0.63 beat American Oncology Network's score of -0.96 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment American Oncology Network Negative Aclarion Positive Is AONC or ACONW more profitable? Company Net Margins Return on Equity Return on Assets American Oncology NetworkN/A N/A N/A Aclarion N/A N/A N/A SummaryAmerican Oncology Network beats Aclarion on 2 of the 3 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$219.43M$5.62B$9.30BDividend YieldN/A5.90%4.25%4.03%P/E RatioN/A399.1028.5719.58Price / SalesN/A222.54424.2194.37Price / CashN/A47.1436.0257.93Price / BookN/A5.248.135.54Net IncomeN/A-$15.55M$3.24B$257.73M7 Day PerformanceN/A-0.51%2.03%0.95%1 Month PerformanceN/A0.92%8.29%10.68%1 Year PerformanceN/A13.37%28.40%15.67% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.02+4.1%N/A-33.0%$0.00$54.60K0.007AONCAmerican Oncology NetworkN/A$12.51-6.6%N/A+627.9%$0.00$1.34B0.001,520News CoverageGap DownDHACWDigital Health AcquisitionN/A$0.05-0.2%N/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$23.05-0.7%N/A+4.9%$0.00$234.01M0.00230High Trading VolumeOTRKPOntrakN/A$0.23-4.7%N/A-8.2%$0.00$10.84M0.00250High Trading VolumePIIIWP3 Health PartnersN/A$0.01-0.9%N/AN/A$0.00$1.49B0.00500Gap DownTALKWTalkspaceN/A$0.09-9.0%N/A-4.3%$0.00$194.36M0.00500Gap DownTOIIWOncology InstituteN/A$0.08+13.9%N/A+261.3%$0.00$403.15M0.00660Positive NewsHigh Trading VolumeNTRANatera1.6231 of 5 stars$161.75+2.1%$184.63+14.1%+41.7%$22.09B$1.70B-110.034,434News CoverageFMSFresenius Medical Care AG & Co. KGaA3.588 of 5 stars$27.49-0.1%$27.80+1.1%+36.4%$16.13B$19.49B24.541,384HIMSHims & Hers Health2.0605 of 5 stars$51.14+4.5%$39.58-22.6%+139.3%$11.45B$1.48B74.121,637Trending NewsAnalyst DowngradeInsider Trade Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.